SI Money Map · Client

NOVARTIS and SI policy

NOVARTIS is the client on 7 federal lobbying reports that name SI issues, Q1 2025 to Q3 2026, disclosing $14.0M by the amount rule: $7.8M in 2025 and $6.2M in 2026 so far. It filed 7 reports for itself. Rank 33 of 1,245 clients. Read from LDA.gov, Nov 17, 2026. Amounts are filing totals for all issues on each filing.

Updated Nov 17, 2026Rank 337 SI filings

$14.0MReported, all quarters
7SI filings
7Quarters with filings
9Lobbyist IDs on SI

Over time

Quarter by quarter

Q1 2025 to Q3 2026. Q3 2026 reports were due Oct 20, 2026.

NOVARTIS: reported amount by quarterBy the amount rule: the in-house report when there is one, else the outside firms' reports.
$0$2.5M$5MQ1 25: $4.2MQ2 25: $920KQ3 25: $1.7MQ4 25: $1.0MQ1 26: $3.9MQ2 26: $1.4MQ3 26: $840K$4.2M$840KQ1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26$0$2.5M$5MQ1 25: $4.2MQ2 25: $920KQ3 25: $1.7MQ4 25: $1.0MQ1 26: $3.9MQ2 26: $1.4MQ3 26: $840K$4.2M$840KQ1 25Q3 25Q1 26Q3 26
SI filings and amounts by quarter. Counted: the in-house amount when NOVARTIS filed an SI report for itself that quarter, otherwise the outside firms' amounts. Subcontracts are never added.
QuarterFilingsIn-houseOutside firmsCounted
Q3 20261$840,000none$840,000
Q2 20261$1,410,000none$1,410,000
Q1 20261$3,930,000none$3,930,000
Q4 20251$1,000,000none$1,000,000
Q3 20251$1,700,000none$1,700,000
Q2 20251$920,000none$920,000
Q1 20251$4,168,000none$4,168,000

The filings

Every SI filing for NOVARTIS

Each LD-2 report with at least one issue line that names SI, newest first, with the link to the filing on LDA.gov. "SI lines" shows how many of the filing's issue lines name SI.

Amount: income reported by an outside firm, or expenses reported in-house, for all issues on the filing.
QuarterFiled byAmountSI linesIssue codes and billsSource
Q3 2026Q3, posted Oct 20, 2026
NOVARTISIn-house
$840,000
1 of 7
Health IssuesH.R. 2214, H.R. 3037, H.R. 5256, H.R. 8800, H.R. 946, H.R. 9504, H.R. 9599, S. 1500 ...
Q2 2026Q2, posted Jul 20, 2026
NOVARTISIn-house
$1,410,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 3037, H.R. 5256, H.R. 8800, H.R. 946, H.R. 9504, H.R. 9599 ...
Q1 2026Q1, posted Apr 20, 2026
NOVARTISIn-house
$3,930,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 3037, H.R. 5256, H.R. 946, S. 1500, S. 1682, S. 864 ...
Q4 2025Q4, posted Jan 20, 2026
NOVARTISIn-house
$1,000,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 3037, H.R. 5256, H.R. 946, S. 1500, S. 1682, S. 864 ...
Q3 20253A, posted Mar 9, 2026
NOVARTISIn-house
$1,700,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 3037, H.R. 5256, H.R. 946, S. 1500, S. 864, S. 932
Q2 20252A, posted Mar 9, 2026
NOVARTISIn-house
$920,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 3037, H.R. 946, S. 1500, S. 864
Q1 2025Q1, posted Apr 21, 2025
NOVARTISIn-house
$4,168,000
1 of 7
Health IssuesH.R. 1262, H.R. 2214, H.R. 946, S. 864

In their own words

What the filings say

The SI issue lines, quoted as filed: newest first, repeats left out, long lines cut short. The words are the filers'; the filings are public records.

Names as filed
NOVARTIS
Issue codes
Health Issues (7)
Bills named
H.R. 2214 (7), H.R. 946 (7), S. 864 (7), H.R. 1262 (6), H.R. 3037 (6), S. 1500 (6), H.R. 5256 (5), S. 932 (4), S. 1682 (4), H.R. 8800 (2), H.R. 9504 (2), H.R. 9599 (2)
  1. "Direct to Consumer Advertising 340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act HR. 5256 - 340B Affording Care for Communities and Ensuring a Strong Safety-Net ..."

    Health Issues, filed by NOVARTIS. The filing
  2. "340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act HR. 5256 - 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend ..."

    Health Issues, filed by NOVARTIS. The filing
  3. "340B Drug Discount Program - Program Implementation & Oversight 340B PATIENTS Act of 2024 340B Drug Discount Program - RFI for SUSTAIN 340B Act 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act(340B ACCESS Act) To amend title III of ..."

    Health Issues, filed by NOVARTIS. The filing

Embed

Put this card on any page

A plain image that links back here, with its source printed on it. Free under CC BY 4.0. Filings, not influence. The SI Money Map shows what federal disclosure filings report: who paid for lobbying, which issues and bills the filings name, and what super PACs raised and spent. It does not show influence, intent or results, and it takes no side.

Copy the embed
<a href="https://tsio.si/money-map/novartis/"><img src="https://tsio.si/money-map/novartis/card.svg" width="480" height="240" alt="The SI Money Map: NOVARTIS, $14.0M reported on SI lobbying filings"></a>
SI Money Map card for NOVARTIS